Tradestie Institutional Equity Comparison Engine
CLX vs UL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CLX Overall Edge
CLX Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Clorox Company (CLX) driven by superior Valuation, Momentum & Technical, Options & Structure while UL counters with relative strength in Growth & Margin. Fundamentally, CLX trades at 17.6x Forward P/E with 14.3% operating margin (+33.3% YoY revenue) versus UL at 18.5x Forward P/E and 20.0% operating margin (+0.5% YoY). In options structure, CLX sits in SURGE (25th %ile IV; Dealer Gamma Walls on Pro) against UL sits in UNCLASSIFIED (13th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CLX
CLX 17.6x vs UL 18.5x Fwd P/E
Growth & Margin Winner
UL
Op Margin 14.3% vs 20.0% ยท YoY +33.3% vs +0.5%
Momentum & Technical Winner
CLX
1Y +6.4% vs +8.4% ยท 52W Pos 51% vs 45%
Options & Structure Winner
CLX
SURGE (25th %ile IV) vs UNCLASSIFIED (13th %ile IV)
CLX
NYSE
Clorox Company
Specialty Cleaning, Polishing And Sanitation Preparations
$104.73
-0.16% 1D
Market Cap
$12.7B
1M Return
+18.13%
1Y Return
+6.4%
Forward P/E
17.6x
Unified AI Score
29.7 / 100
SELL
Tech 50.0
Fund 32.0
Flow 57.0
Mom 50.0
UL
NYSE
Unilever plc
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
$63.82
+0.73% 1D
Market Cap
$136.4B
1M Return
-4.75%
1Y Return
+8.41%
Forward P/E
18.5x
Unified AI Score
46.7 / 100
HOLD
Tech 47.0
Fund 45.0
Flow 50.0
Mom 36.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CLX +6.4%
UL +8.41%
Spread: +2.01 pp (UL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CLX TTM Op. Margin: 14.3%
UL TTM Op. Margin: 20.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CLX vs UL. Trailing 12-month operating profitability (CLX 14.3% vs UL 20.0%) and valuation multiples (CLX 17.6x vs UL 18.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CLX | UL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.7B | $136.4B | Larger Scale | UL |
| Trailing P/E Ratio Valuation | 18.9x | 13.0x | Lower Multiple | UL |
| Forward P/E Ratio Valuation | 17.6x | 18.5x | Lower Multiple | CLX |
| Revenue Growth (YoY) Growth | +33.3% | +0.5% | Higher Growth | CLX |
| Operating Margin (TTM) Profitability | 14.3% | 20.0% | Higher Margin | UL |
| Net Profit Margin Profitability | 9.4% | 18.3% | Higher Margin | UL |
| Return on Equity (ROE) Capital Efficiency | 53.4% | 31.9% | Higher ROE | CLX |
| 52-Week Range Position Momentum | 51% ($79โ$129) | 45% ($55โ$75) | Stronger Trend | CLX |
| Beta / 30D Volatility Risk Regime | 0.43ฮฒ ยท 37% Vol | -0.03ฮฒ ยท 24% Vol | Lower Realized Risk | UL |
| Unified Institutional Score Composite Signal | 29.7 / 100 (SELL) | 46.7 / 100 (HOLD) | Higher Composite | UL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CLX vs UL Buy Guide
CLX
SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
25th %ile
IV Regime
Balanced (25thโ60th %ile)
UL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
13th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CLX nor UL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.